Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;13(4):681-690.
doi: 10.1007/s13193-022-01550-6. Epub 2022 May 10.

Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review

Affiliations
Review

Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review

Nader Salari et al. Indian J Surg Oncol. 2022 Dec.

Abstract

Chrysin is a natural bioactive compound that is extracted from many trees, honey, and propolis. Chrysin has several pharmacological activities such as anti-inflammatory, anti-cancer, and antioxidant properties. This study was performed to evaluate the anti-cancer activities of chrysin in cancer therapy. The present study was conducted by systematic review of studies published up to August 2021. Related studies were identified by searching Web of Science (WoS), PubMed, Science Direct, SID, MagIran, Scopus, and Google Scholar databases. The keywords of chrysin, cancer, anti-cancer, and cancer therapy were used for searching. The quality of the studies was assessed by the CONSORT checklist. A total of 21 studies were identified. The results of studies showed that chrysin has an anticancer effect by stimulating apoptosis in a wide range of human cells and rats. Chrysin is also an important factor in inhibiting tumor growth and neoplasticity. Chrysin inhibits the growth and proliferation of cancer cells by inducing cytotoxic effects. Therefore, due to the antitumor effects of chrysin and its safety and non-toxicity towards normal cells, this compound can be considered as an adjuvant along with chemotherapeutic agents in cancer treatment.

Keywords: A systematic review; Anti-cancer; Cancer therapy; Chrysin.

PubMed Disclaimer

Conflict of interest statement

Competing InterestsThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic of chrysin sources and its health claims
Fig. 2
Fig. 2
Flow chart indicating the stages of article selection in this systematic review and meta-analysis (PRISMA 2009)

Similar articles

Cited by

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
    1. Stratton M, Campbell P, Futreal P. The cancer genome. Nat [Internet] 2009;458(7239):719–724. doi: 10.1038/nature07943. - DOI - PMC - PubMed
    1. Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ, Organization WH (2001) Cancer incidence, mortality and survival by site for 14 regions of the world
    1. Taheri NS, Nosrat SB, Aarabi M, Tabiei MN, Kashani E, Rajaei S, et al. Epidemiological pattern of breast cancer in Iranian women: is there an ethnic disparity? Asian Pac J Cancer Prev. 2012;13(9):4517–4520. doi: 10.7314/APJCP.2012.13.9.4517. - DOI - PubMed
    1. Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70(6):443–459. doi: 10.3322/caac.21637. - DOI - PubMed

LinkOut - more resources